+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Diabetes and Cardiovascular Health · Registering as Listener

ICDACH
📅 23 – 24 Mar 2027 📍 Cardiff, UK 👥 Standard / Physical Participation
Listener Registration From
$185
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Diabetes and Cardiovascular Health
ModeStandard / Physical
ParticipationListener
Registration fee$185.00
Bank charges (5.8%)$10.73
Total payable $195.73

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 6 SDG 9

This track will explore the intricate relationship between diabetes and cardiovascular diseases, focusing on shared pathophysiological mechanisms. Emphasis will be placed on how metabolic dysregulation contributes to cardiovascular complications in diabetic patients.

This session will highlight recent advancements in diabetes management, including novel pharmacotherapies and lifestyle interventions. Participants will discuss the implications of these innovations for improving patient outcomes and quality of life.

This track will delve into the pathophysiology of diabetic cardiomyopathy, examining the underlying mechanisms that lead to cardiac dysfunction in diabetes. Clinical strategies for early detection and management will also be addressed.

This session will focus on the interplay between hypertension and diabetes, highlighting their combined impact on cardiovascular health. Discussions will include risk factor management and therapeutic approaches to mitigate cardiovascular risks.

This track will investigate the accelerated atherosclerotic processes observed in individuals with diabetes. Researchers will present findings on the role of glucose and lipid metabolism in the progression of cardiovascular disease.

This session will address the prevalence and management of heart failure in diabetic populations. Clinical insights into the diagnosis, treatment, and prevention strategies will be shared by leading experts in the field.

This track will examine the relationship between glycemic control and cardiovascular health in diabetic patients. Evidence-based strategies for optimizing glycemic levels to reduce cardiovascular risk will be discussed.

This session will explore the role of endocrine factors in cardiovascular disease among diabetic patients. The impact of hormonal regulation on cardiovascular risk and management strategies will be a focal point of discussion.

This track will investigate the link between diabetic nephropathy and increased cardiovascular risk. Participants will explore mechanisms of kidney damage and its implications for heart health in diabetic individuals.

This session will focus on the effectiveness of lifestyle modifications in managing diabetes and reducing cardiovascular risks. Evidence-based approaches will be presented, emphasizing the importance of diet, exercise, and behavior change.

This track will highlight cutting-edge research on emerging therapies aimed at addressing both diabetes and cardiovascular disease. Discussions will include the potential of novel agents and combination therapies to improve patient outcomes.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED